Onderneming Tiziana Life London S.E.
Aandelen
TILS
GB00BKWNZY55
Biotechnologie & Medisch Onderzoek
Vakgebied
Aantal werknemers: 9
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Gabriele Cerrone
CEO | Chief Executive Officer | 52 | 11-02-98 |
Keeren Shah
DFI | Director of Finance/CFO | 47 | - |
Vaseem Palejwala
CTO | Chief Tech/Sci/R&D Officer | - | 01-01-17 |
Matthew Davis
COO | Chief Operating Officer | - | 01-07-22 |
Paul Spencer
IRC | Investor Relations Contact | - | 01-12-22 |
William Clementi
PRN | Corporate Officer/Principal | - | 01-09-23 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
John Brancaccio
BRD | Director/Board Member | 76 | 01-07-20 |
Willy Simon
BRD | Director/Board Member | 72 | 01-11-15 |
Gabriele Cerrone
CEO | Chief Executive Officer | 52 | 11-02-98 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 194 612 289 | 63 373 729 ( 32,56 %) | 0 | 32,56 % |
Participaties
Naam | Aandelen | % | Totale waarde |
---|---|---|---|
ACCUSTEM SCIENCES, INC. 11.80% | 1 337 970 | 11.80% | 468 290 $ |
Bedrijfsgegevens
Sector
Vaira. 1 jan. | Kapi. | |
---|---|---|
+1,51% | 42,75 mld. | |
+49,22% | 41,61 mld. | |
+8,57% | 41,34 mld. | |
-12,36% | 26,59 mld. | |
+8,92% | 25,49 mld. | |
-25,13% | 18,12 mld. | |
+29,17% | 12,24 mld. | |
-3,12% | 11,76 mld. | |
+6,35% | 11 mld. |